ALC:NYE-Alcon AG (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 98.5

Change

-2.26 (-2.24)%

Market Cap

USD 49.70B

Volume

1.55M

Analyst Target

USD 65.36
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

-2.77 (-1.18%)

USD 67.65B
RMD ResMed Inc

-0.89 (-0.35%)

USD 35.98B
BAX Baxter International Inc

-0.45 (-1.12%)

USD 20.54B
AVTR Avantor Inc

-0.33 (-1.21%)

USD 18.49B
TFX Teleflex Incorporated

-4.61 (-1.87%)

USD 11.63B
ATR AptarGroup Inc

+0.04 (+0.03%)

USD 10.16B
BLCO Bausch + Lomb Corp

+0.76 (+4.27%)

USD 6.26B
STVN Stevanato Group SpA

-0.21 (-1.09%)

USD 5.62B
WRBY Warby Parker Inc

-0.12 (-0.80%)

USD 1.57B
INFU InfuSystems Holdings Inc

-0.09 (-1.38%)

USD 0.14B

ETFs Containing ALC

CHSRI:SW UBS ETF (CH) - MSCI Switz.. 5.01 % 0.00 %

+0.11 (+0.20%)

N/A
CHSRIA:SW UBS ETF (CH) MSCI Switzer.. 5.01 % 0.00 %

+0.11 (+0.20%)

N/A
CHSRII:SW UBS(Lux)Fund Solutions .. 4.98 % 0.00 %

+0.07 (+0.20%)

N/A
CHSR:XETRA UBS(Lux)Fund Solutions .. 4.94 % 0.00 %

+0.08 (+0.20%)

USD 0.17B
DXS0:XETRA Xtrackers SLI UCITS ETF 1.. 4.51 % 0.00 %

+0.70 (+0.20%)

USD 0.26B
XSLI:SW Xtrackers SLI UCITS ETF 1.. 4.43 % 0.00 %

+0.40 (+0.20%)

USD 0.28B
SLICHA:SW UBS ETF (CH) – SLI® (C.. 4.40 % 0.00 %

+1.00 (+0.20%)

USD 32,912.73B
EXI1:XETRA iShares SLI UCITS ETF (DE.. 4.39 % 0.00 %

+0.38 (+0.20%)

USD 0.37B
SMIEX:SW iShares SLI UCITS ETF (DE.. 4.39 % 0.00 %

+0.64 (+0.20%)

USD 5,933.96B
CSSLI:SW iShares SLI® ETF (CH) 4.37 % 0.00 %

+0.70 (+0.20%)

USD 0.58B
CBCH30:SW 3.78 % 0.00 %

N/A

N/A
C030:F Lyxor DJ Switzerland Tita.. 3.64 % 0.00 %

+0.02 (+0.20%)

USD 0.01B
ESRG:LSE Amundi Index Solutions - .. 3.54 % 0.00 %

+34.50 (+0.20%)

USD 2.11B
ESDG:LSE Amundi Index Solutions - .. 3.54 % 0.00 %

+32.00 (+0.20%)

USD 0.18B
EUSRI:PA Amundi Index Solutions - .. 3.26 % 0.00 %

+0.24 (+0.20%)

USD 2.09B
XSMI:XETRA Xtrackers Switzerland UCI.. 3.23 % 0.00 %

+0.26 (+0.20%)

N/A
MIVB:XETRA Amundi Index Solutions - .. 3.21 % 0.00 %

+0.12 (+0.20%)

USD 2.10B
ACU7:XETRA Amundi Index Solutions - .. 3.21 % 0.00 %

+0.15 (+0.20%)

USD 0.13B
XSMC:SW Xtrackers Switzerland UCI.. 3.16 % 0.00 %

+0.28 (+0.20%)

USD 0.47B
XSMI:SW Xtrackers Switzerland UCI.. 3.16 % 0.00 %

+0.42 (+0.20%)

USD 1.23B
ESRU:LSE Amundi Index Solutions - .. 3.12 % 0.00 %

N/A

N/A
AGNG Global X Aging Population.. 3.11 % 0.00 %

-0.25 (0.20%)

USD 0.06B
ESDU:LSE Amundi Index Solutions - .. 3.09 % 0.00 %

+1.19 (+0.20%)

N/A
FLSW Franklin FTSE Switzerland.. 2.82 % 0.09 %

-0.14 (0.20%)

USD 0.06B
CHEUR:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHEURD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHUSD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

+0.16 (+0.20%)

N/A
CHUSDD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
XSDR:LSE Xtrackers MSCI Europe Hea.. 2.77 % 0.00 %

-110.00 (0.20%)

USD 0.21B
DXSE:XETRA Xtrackers - Stoxx Europe .. 2.77 % 0.00 %

-2.10 (0.20%)

USD 0.14B
SWEUAH:SW UBS ETF (CH) – MSCI Swi.. 2.77 % 0.00 %

N/A

USD 226,274.20B
SWUSAH:SW UBS ETF (CH) – MSCI Swi.. 2.76 % 0.00 %

+0.20 (+0.20%)

USD 226,274.21B
SW2CHA:SW UBS(Lux)Fund Solutions .. 2.76 % 0.00 %

+0.13 (+0.20%)

USD 0.44B
SW2CHB:SW UBS(Lux)Fund Solutions .. 2.76 % 0.00 %

+0.05 (+0.20%)

USD 1.41B
SW2UKD:SW UBS(Lux)Fund Solutions .. 2.76 % 0.00 %

+0.04 (+0.20%)

USD 0.04B
S2HGBD:SW UBS(Lux)Fund Solutions .. 2.76 % 0.00 %

N/A

USD 0.06B
S2HGBA:SW UBS(Lux)Fund Solutions .. 2.76 % 0.00 %

N/A

USD 8.49M
CHSPI:SW iShares Core SPI® ETF (C.. 2.66 % 0.00 %

+0.46 (+0.20%)

USD 3.37B
STW:PA SPDR® MSCI Europe Health.. 2.56 % 0.00 %

-1.60 (0.20%)

USD 0.82B
SPYH:XETRA SPDR® MSCI Europe Health.. 2.56 % 0.00 %

-1.80 (0.20%)

USD 0.66B
STWX:SW SPDR® MSCI Europe Health.. 2.56 % 0.00 %

-1.15 (0.20%)

USD 0.82B
ESIH:LSE iShares MSCI Europe Healt.. 2.54 % 0.00 %

-0.02 (0.20%)

USD 0.68B
HEAE:LSE SPDR® MSCI Europe Health.. 2.50 % 0.00 %

-0.78 (0.20%)

N/A
ESIH:F Ishares VI PLC - Ishares .. 2.46 % 0.00 %

-0.09 (0.20%)

USD 0.63B
ESIH:XETRA iShares MSCI Europe Healt.. 2.46 % 0.00 %

-0.06 (0.20%)

USD 0.60B
EXV4:XETRA iShares STOXX Europe 600 .. 2.33 % 0.00 %

-0.92 (0.20%)

USD 0.70B
SXDPEX:SW iShares STOXX Europe 600 .. 2.33 % 0.00 %

N/A

USD 0.44B
CHDIV:SW UBS ETF (CH) - MSCI Switz.. 2.26 % 0.00 %

-0.01 (0.20%)

USD 1,244,681.59B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.26 % 0.00 %

+0.02 (+0.20%)

N/A
CEFA Global X S&P Catholic Val.. 1.50 % 0.00 %

-0.16 (0.20%)

USD 0.01B
EWL iShares MSCI Switzerland .. 0.00 % 0.47 %

-0.18 (0.20%)

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
RNDM 0.00 % 0.65 %

N/A

N/A
HLTH:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

-1.53 (0.20%)

N/A
UC93:LSE UBS MSCI Switzerland 20/3.. 0.00 % 0.00 %

+12.75 (+0.20%)

USD 8.49M
UC94:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+10.50 (+0.20%)

USD 0.06B
DBXS:F Xtrackers - Switzerland U.. 0.00 % 0.00 %

N/A

N/A
DXS0:F Xtrackers - SLI UCITS ETF 0.00 % 0.00 %

+0.05 (+0.20%)

N/A
DXSE:F Xtrackers Stoxx Europe 60.. 0.00 % 0.00 %

N/A

N/A
EL4X:F Deka DAXplus Maximum Divi.. 0.00 % 0.00 %

+0.58 (+0.20%)

N/A
EXI1:F iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

-0.04 (0.20%)

N/A
EXV4:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
EXV5:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
MIVB:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.16 (0.20%)

N/A
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-3.40 (0.20%)

N/A
C030:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.06 (0.20%)

USD 0.13B
DBXS:XETRA Xtrackers - Switzerland U.. 0.00 % 0.00 %

+0.26 (+0.20%)

USD 1.34B
EL4X:XETRA Deka DAXplus Maximum Divi.. 0.00 % 0.00 %

+0.50 (+0.20%)

USD 0.29B
1391:TSE 0.00 % 0.00 %

N/A

N/A
CSSMI:SW iShares SMI® ETF (CH) 0.00 % 0.00 %

+0.42 (+0.20%)

USD 2.01B
SMICHA:SW UBS ETF (CH) – SMI® (C.. 0.00 % 0.00 %

+0.36 (+0.20%)

USD 17,142.72B
SPICHA:SW UBS ETF (CH) – SPI® (C.. 0.00 % 0.00 %

+0.26 (+0.20%)

USD 131,872.43B
SWICHA:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

+0.02 (+0.20%)

USD 226,274.25B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.09% 89% A- 90% A-
Dividend Return 0.34% 22% F 6% D-
Total Return 26.43% 89% A- 88% B+
Trailing 12 Months  
Capital Gain 20.22% 74% C 71% C-
Dividend Return 0.32% 22% F 4% F
Total Return 20.55% 68% D+ 65% D
Trailing 5 Years  
Capital Gain 65.69% 73% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 65.69% 73% C 74% C
Average Annual (5 Year Horizon)  
Capital Gain 10.68% 74% C 70% C-
Dividend Return 10.92% 74% C 65% D
Total Return 0.24% 11% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 17.08% 89% A- 59% D-
Risk Adjusted Return 63.91% 100% F 80% B-
Market Capitalization 49.70B 93% A 96% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.